ASN QBank Pearls - Fluid Compartments and Electrolyte Disorders Flashcards
how much volume of 0.9% saline contributes to increasing the volume of the intravascular space?
25%
illicit drug that can cause AKI 2/2 nontraumatic rhabdomyolysis
MDMA (ecstasy)
most efficient and effective means of removing lithium
HD
normal kidneys echogenicity
less than that of pancreas and equal or less than that of liver and spleen
hypercholesterolemia with lipoprotein X associated with cholestatic or obstructive jaundice is a cause of
pseudohyponatremia
risk factors for osmotic demyelination syndrome (ODS)
- alcoholism
- serum Na+ ≤ 105 mEq/L
- liver disease
- malnutrition
complication of hypomagnesemia or hypermagnesemia
hypocalcemia
differential diagnosis for hypercalcemia with low PTH, normal 25(OH)D, and low 1,25(OH)2D
- hyperthyroidism
- malignancy
- immobilization
- Paget’s disease
- milk-alkali syndrome
initial therapy of moderate to severe hypercalcemia includes
simultaneous administration of;
- isotonic saline
- calcitonin
- bisphosphonate
classic triphasic response following injury or transection of the pituitary stalk
- DI occurs because vasopressin cannot be released from nerve terminals d/t interruption of nerve impulses
- SIADH results from unregulated release of stored vasopressin from degenerating neurons
- permanent DI once vasopressin stores are depleted
can cause central pontine and extrapontine myelinolysis, similar to what occurs after rapid correction of chronic hyponatremia
acute hypernatremia; should be rapidly corrected
ODS prognosis even if initially ventilator dependent
complete neurological recovery in up to 1/3 of cases
mechanism by which hypermagnesemia causes hypocalcemia
binds to calcium-sensing Rs and reduces PTH
complications of acute hypermagnesemia
- hypotension
- hyperkalemia
- hypocalcemia
- at higher levels, heart block and cardiac arrest
familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) gene mutations
claudin-16 gene
medication class that inhibits claudin-16 gene
calcineurin inhibitors (cyclosporine, tacrolimus, and pimecrolimus)
medications that cause hypomagnesemia d/t renal magnesium wasting in distal tubule
cetuximab, panitumumab, and matuzumab
calcineurin inhibitors primarily reduce expression of claudin 16 where?
ascending limb in LOH
what test BEST demonstrates pseudohyponatremia?
plasma osmolality
MOST appropriate therapy for hyperuricemia prior to tumor-specific chemotherapy if G6PD deficiency?
allopurinol
no longer recommended for tumor lysis syndrome (TLS)
urinary alkalinization d/t r/o calcium-phosphate crystal deposition (acute phosphate nephropathy) and hypoxanthine/xanthine crystal deposition
renal complications of cisplatin
- hyponatremia 2/2 cisplatin-induced renal salt wasting
- ATN
- tubulopathies:
- proximal tubulopathy/Fanconi syndrome
- Mg2+ wasting
- nephrogenic DI
- CKD
MOST common electrolyte disturbance associated with cetuximab
hypomagnesemia
complications of ecstasy toxicity
- hyponatremia 2/2 SIADH and excessive hypotonic fluid ingestion
- seizures (from hyponatremia)
- lactic acidosis
- AKI 2/2 rhabdomyolysis
mechanisms of hyponatremia 2/2 IVIG
- pseudohyponatremia from the immunoglobulin
- true hyponatremia from the associated carrier (sucrose, maltose)
women who donate a kidney before becoming pregnant
increased risk for adverse outcomes DURING pregnancy
use of ACE inhibitors during pregnancy?
contraindicated, but can be used during breastfeeding postpartum
polyuria d/t high solute intake
How to calculate daily solute excretion:
Urine studies:
24hr urine vol: 6L
Na 27 mEq/L / K 13 mEq/L
Urea 32g/24hrs
Uosm 267 mOsm/H20
Consider solute diuresis if :
- Uosm >300 mOsm/day (lab result)
- Daily solute excretion >1000mg/day (you calculate this)
-> Calc daily solute excretion (approximates daily solute intake)
-> Uosm (mOsm/kg) x Uvol (L/day) = daily urinary solute (mOsm/day)
note: typical daily solute intake 600-900 mOsm/day
How to determine the major contributor to urinary osmoles in the daily solute excretion:
Urine studies:
24hr urine vol: 6L
Na 27 mEq/L / K 13 mEq/L
Urea 32g/24hrs
Uosm 267 mOsm/H20
Uosm (mOsm/kg) x Uvol (L/day) = daily urinary solute (mOsm/day)
- 267 x 6 = 1602 mOsm/day
=> convert urea to mOsm:
32g/ 6L = 5.3g/L -> 530mg/dL urine urea
=> divide by 2.8 to get mOsm/L
530 mg/dL / 2.8 = 189 mOsm/L (x6L for this patient in 24hrs)
= 1135 mOsm/day is urine urea
=> 2x [UNa + UK] x vol per day = remaining mOsm
2x [27 + 13] x 6L = 480 mOsm
**1135 mOsm urine urea > 480 mOsm urine Na +K
how to calculate protein intake:
50kg patient
Urine studies:
24hr urine vol: 6L
Na 27 mEq/L / K 13 mEq/L
Urea 32g/24hrs
Uosm 267 mOsm/H20
urine urea used to estimate protein intake:
Calculated protein intake = [urine urea + (kg × 0.031 g nitrogen/kg/day) × 6.25.
In this case:
[32 g/d + (50 kg × 0.031g nitrogen/kg/day)] × 6.25 = 210 g calculated daily protein intake.
Daily target protein 0.8g/kg/day without CKD